Literature DB >> 17413979

Carcinomas of ovary and lung with clear cell features: can immunohistochemistry help in differential diagnosis?

Nicole R Howell1, Wenxin Zheng, Liang Cheng, Carmen Tornos, Philip Kane, Michael Pearl, Eva Chalas, Sharon X Liang.   

Abstract

Metastatic lung carcinomas with clear cell morphology can be confused with primary ovarian clear cell carcinomas. We performed immunohistochemical stains in 14 cases of non-small cell lung carcinomas with clear cell features and 14 cases of ovarian clear cell carcinomas using a panel of markers, including thyroid transcription factor 1 (TTF-1), carcinoembryonic antigen (CEA), Wilms tumor gene 1, octamer-binding transcription factor 4 (OCT-4), cancer antigen 125 (CA-125), estrogen receptor, and progesterone receptor. Among non-small cell lung carcinomas with clear cell features, 87.5% of adenocarcinomas (or 50% overall frequency in lung carcinomas) were positive for TTF-1, whereas none of the ovarian clear cell carcinomas were positive (P = 0.002). All 14 ovarian clear cell carcinomas stained for CA-125 as compared with 1 non-small cell lung carcinoma (P < 0.001). On the other hand, 85% of non-small cell lung carcinomas stained for CEA, whereas none of the ovarian clear cell carcinomas did (P < 0.001). Interestingly, 4 ovarian clear cell carcinomas (28%) showed positive staining for the germ cell marker OCT-4. Either lung or ovarian carcinomas stained for Wilms tumor gene 1, estrogen receptor, or progesterone receptor very infrequently; and the difference between the 2 groups was not statistically significant. Our results suggest that an immunohistochemical panel consisting of TTF-1, CEA, CA-125, and OCT-4 is helpful in distinguishing most pulmonary and ovarian carcinomas with clear cell features.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17413979     DOI: 10.1097/01.pgp.0000233166.56385.d0

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  5 in total

1.  HNF-1β in ovarian carcinomas with serous and clear cell change.

Authors:  Deborah DeLair; Guangming Han; Julie A Irving; Samuel Leung; Carol A Ewanowich; Teri A Longacre; Cyril B Gilks; Robert A Soslow
Journal:  Int J Gynecol Pathol       Date:  2013-11       Impact factor: 2.762

2.  Clear cell adenocarcinoma of the uterine cervix in a young pregnant woman: a case report with immunohistochemical study.

Authors:  Tadashi Terada
Journal:  Med Oncol       Date:  2010-01-07       Impact factor: 3.064

3.  Toward an understanding of the pathophysiology of clear cell carcinoma of the ovary (Review).

Authors:  Chiharu Uekuri; Hiroshi Shigetomi; Sumire Ono; Yoshikazu Sasaki; Miyuki Matsuura; Hiroshi Kobayashi
Journal:  Oncol Lett       Date:  2013-08-28       Impact factor: 2.967

4.  Analysis of mutational and clinicopathologic characteristics of lung adenocarcinoma with clear cell component.

Authors:  Chang Gu; Xufeng Pan; Rui Wang; Yuan Li; Xuxia Shen; Jianxin Shi; Haiquan Chen
Journal:  Oncotarget       Date:  2016-04-26

5.  Occult ovarian clear-cell carcinoma diagnosed as primary adenocarcinoma of the lung: A case report of a diagnostic pitfall for clinicians and pathologists.

Authors:  Terufumi Kubo; Yoshihiko Hirohashi; Hiromi Fujita; Shintaro Sugita; Yasuhiro Kikuchi; Tomoyo Shinkawa; Munehide Nakatsugawa; Mitsuhiro Tsujiwaki; Yuta Sudo; Yuichiro Asai; Yasuaki Umeda; Hiroki Takahashi; Tadashi Hasegawa; Toshihiko Torigoe
Journal:  Respir Med Case Rep       Date:  2018-10-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.